跳至主要内容
临床试验/NCT06151145
NCT06151145进行中(未招募)不适用

Stepped Care for Weight Loss Maintenance

Johns Hopkins University2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2024年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
180
试验地点
2
主要终点
Weight (kg) change for STEP versus usual care

研究概览

简要总结

This study is a 3-group, parallel design, randomized controlled trial (RCT) in approximately 258 adults with obesity that will investigate whether a 16-week behavioral weight loss treatment and a 52-week stepped-care digital health intervention can improve the maintenance of a ≥ 5% weight loss.

16-week run-in (Phase 1). To qualify for randomization, participants must lose ≥ 5% of initial weight in the 16-week run-in. This loss will be achieved with the provision of weekly-group lifestyle counseling, which includes a partial meal replacement diet.

52-week randomized trial of 3 weight loss maintenance strategies (Phase 2): Participants who have achieved ≥ 5% weight loss during Phase 1 will be randomly assigned to 1 of 3 groups:

  1. Participants in the Usual Care group will be emailed monthly educational modules with information on maintaining weight loss.
  2. Participants in the SELF group will receive a wireless "smart" body weight scale and a wearable physical activity tracker, and daily text messages with tailored feedback to assist in weight loss maintenance.
  3. Participants in the STEP group will be enrolled in an intervention that consists of 4 steps that are progressive and based on response to treatment. After 13 weeks at each step, participants who do not maintain a ≥5% weight loss or regain 2 percentage points of weight from the participants randomization value will move to a higher intensity step. Participants who maintain weight loss will stay at the same step.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI>/=30 kg/m2 or >/=27 kg/m2 with an obesity-related complication
  • Age 18-70 years
  • Completion of baseline assessment tasks
  • Ability to engage in physical activity
  • Own a smartphone capable of receiving text-messages and syncing to weight scales and physical activity trackers
  • Home wireless access

排除标准

  • Serious medical condition or psychiatric condition that may pose a risk to the participant during intervention, cause a change in weight, or limit ability to adhere to the behavioral recommendations of the program
  • Pregnant or planning pregnancy in the next 1.5 years
  • Weight>440 lbs
  • Planned move out of the area in the next 1.5 years
  • Recently began a course of or changed the dosage of medication that can cause significant change in weight
  • History of bariatric surgery
  • Weight loss of >5% in the previous 6 months
  • Household member already participating in study

研究组 & 干预措施

Usual care

Active Comparator

Usual care

干预措施: Usual care (Behavioral)

Text-message intervention with digital tools (SELF)

Experimental

Text-message intervention

干预措施: SELF (Behavioral)

Stepped Care (STEP)

Experimental

Stepped care

干预措施: STEP (Behavioral)

结局指标

主要结局

Weight (kg) change for STEP versus usual care

时间窗: Baseline, 52 weeks

Weight change (kg) for STEP versus usual care

Weight (kg) change for SELF versus usual care

时间窗: Baseline, 52 weeks

Weight change (kg) for SELF versus usual care

次要结局

  • Change in self-weighing frequency (days) for STEP and SELF versus usual care(Baseline, 52 weeks)
  • Change in daily calorie intake for STEP and SELF vs usual care(Baseline, 52 weeks)
  • Change in physical activity (minutes) for STEP and SELF versus usual care(Baseline, 52 weeks)
  • Weight (kg) change for STEP versus SELF(Baseline, 52 weeks)
  • Change in days of self-weighing for STEP versus SELF(Baseline, 52 weeks)
  • Change in daily calorie intake for STEP versus SELF(Baseline, 52 weeks)
  • Change in self-reported minutes of Physical activity for STEP versus SELF(Baseline, 52 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Stepped Care for Weight Loss Maintenance | 临床试验